Background Terlipressin (triglycyl lysine vasopressin) is a synthetic analogue of
vasopressin, which has been used in the treatment of acute variceal haemorrhage. In …

Promoting the development of oesophageal varices and ascites, portal hypertension
dominates the clinical course of cirrhosis. Varices appear in patients with portal pressure …

Portal hypertension is a major complication of chronic liver disease. Its main clinical
consequence, bleeding from ruptured esophagogastric varices, represents a dramatic …

Background Vasoactive medications such as vasopressin, somatostatin and their analogues
(terlipressin, vapreotide and octreotide) are commonly used for the treatment of acute …

Background/Aim: Ornipressin, a vasopressin analog with potent splanchnic vasoconstrictor
action, has been shown to reverse hepatorenal syndrome. However, its usefulness in …

These guidelines on the management of variceal haemorrhage were commissioned by the
British Society of Gastroenterology under the auspices of the Liver Section. They were …

Upper gastrointestinal bleeding (GIB) is a major complication in cirrhotic patients.
Endoscopy and oesophageal sclerosis are reference treatments and must be done as soon …

Bleeding from esophageal varices is a life threatening complication of portal hypertension.
Primary prevention of bleeding in patients at risk for a first bleeding episode is therefore a …

Cirrhosis is the fifth leading cause of death in adults. Advanced cirrhosis can cause
significant portal hypertension (PH), which is responsible for many of the complications …

Methods: We searched the PubMed, EMBASE, and Cochrane Library databases. The
reference list was also hand-searched. Using a random-effect model, we combined the data …